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approach for atrial septal defects.
Methods: Between May 1998 and May 2008, 166 patients (median age, 44 years) had surgery for atrial septal
defects in our institution. Of these patients, 118 (71%) had a patent foramen ovale (associated with atrial septal
aneurysm in 48 cases), 33 (20%) had a wide ostium secundum defect, 6 (3.6%) had an ostium primum defect, 6
(3.6%) had a sinus venosus defect with abnormal pulmonary vein connection, and 1 (0.6%) had a coronary sinus
defect. In 2 cases (1.2%) patients were referred to our department for surgical correction after failure of interven-
tional occluder placement. All patients were operated on via a right minithoracotomy (mean incision, 5.5 1 cm)
in the fourth intercostal space and under cardiopulmonary bypass.
Results: The HeartPort access system was used in 106 patients (64%), with an endoaortic clamp (central kit in 50
cases and peripheral kit in 56). In the remaining patients (36%), we preferred the Portaclamp system (37 cases) or
the Chitwood clamp (23 cases). Average crossclamp time was 38.4 22.2 minutes with a mean cardiopulmonary
bypass time of 64.9  34.5 minutes. There was no conversion in classic sternotomy. There were no early or late
hospital deaths. Surgical revision was performed in 6 patients for bleeding from the thoracic wall. The mean hos-
pital stay was 5.8 days. At 51 months mean follow-up, 4 patients died of non–cardiac-related causes.
Conclusions: Port-access minimally invasive surgery for atrial septal defects is a safe, less-invasive, reproduc-
ible, and cosmetic operation, providing an excellent outcome and an effective correction, and could be now con-
sidered the standard approach for this type of patient.(J Thorac Cardiovasc Surg 2010;139:139-45)Earn CME credits at
http://cme.ctsnetjournals.org
Surgical repair of atrial septal defects (ASDs) has been per-
formed for more than 50 years and has been considered
superior, compared with medical therapy, in terms of long-
term survival and prevention of functional deterioration.1
Contemporaneously, since 1976, transcatheter closure of
ASDs has gradually become an effective alternative to sur-
gical treatment.2,3 This procedure avoids operative trauma
and surgical wounds and reduces hospital stay, although it
is associated with occasional major complications.4 In this
scenario, the conventional surgical approach was no longer
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The Journal of Thoracic and Careplaced by different minimally invasive techniques that
guarantee a safe surgical act, shorter hospital stay, good
cosmesis, and a durable correction.5-8
During the period from May 1998 and May 2008, ‘‘port-
access’’ surgery, via a right minithoracotomy, became the
standard approach for ASDs at our institution. The aim of
this study is to assess surgical results, long-term outcomes,
and benefits to the patient of a minimally invasive approach
for ASDs.MATERIALS AND METHODS
Patients
From May 1998 to May 2008, 166 patients had surgical repair of ASDs at
our center, and they constitute the subjects of this study. This retrospective
study was performed in accordance with the ethical standards of our ethics
committee and adheres to all legal requirements of our institution. There
were 116 women (70%) and 50 men (30%), with a median age of 44 years
(range, 4–82). Of these patients, 118 (71%) had a patent foramen ovale (as-
sociated with atrial septal aneurysm in 48 cases), 33 (20%) had a wide ostium
secundum defect, 6 (3.6%) had an ostium primum defect (associated with
mitral valve cleft in 3 cases), 6 (3.6%) had a sinus venosus defect with partial
abnormal pulmonary vein connection, and 1 (0.6%) had a coronary sinus
defect. In 2 cases (1.2%), patients were referred to our department for surgi-
cal correction after failure of interventional occluder placement: in 1 patient,
it was an Amplatzer septal occluder (AGA Medical Corporation, Golden
Valley, Minn), and in the other, a Cardia Starr device occluder (Cardia
Inc, Burnsville, Minn). Seventy-nine patients (47.6%) were in New York
Heart Association (NYHA) functional class I, 51 (30.7%) were in class II,rdiovascular Surgery c Volume 139, Number 1 139
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PTFE ¼ polytetrafluoroethyleneand 36 (21.7%) were in class III. The most common clue to the presence of
an ASD was a neurologic symptom (47% of patients), represented by a tran-
sient ischemic attack (61 cases) or the presence of recurring migraine (17
cases). All patients were evaluated by transthoracic or transesophageal
echocardiography preoperatively. Right heart catheterization was necessary
in only 22 patients, and the pulmonary-to-systemic blood flow ratio was de-
termined by oximetry. Coronary angiography was performed in patients
over 35 years of age, but no significant coronary artery disease was found.
Peripheral vascular disease of the iliac or femoral vessels was not an exclu-
sion criterion for the port-access approach because, in these cases, a central
cannulation of the aorta could be always performed. Other preoperative data
of the population are presented in Table 1.
Anesthesia
Double-lumen intubation for single-lung ventilation was used routinely.
There are several reasons why we chose this: (1) high percentage of central
arterial cannulation (53% of cases in our ASD series); (2) less risk of in-
juries to the right lung during the dissection phase and easier preparation
of the patient; (3) no need for cardiopulmonary bypass (CPB) in case of ad-
herences; (4) minimization of the time of deflation of both lungs (before and
after CPB); (5) easier control of possible bleedings (from the heart or the
thoracic wall) at the end of CPB. Both radial arteries were cannulated
when invasive monitoring of the endoaortic clamp was necessary. A 4F
catheter was systematically positioned into the right jugular vein by the an-
esthesiologist, and it was later substituted by the surgeon with a DLP arterial
cannula (Medtronic, Inc, Minneapolis, Minn) for selective venous drainage.
Transesophageal echocardiography was performed in all patients to confirm
and specify the diagnosis, to control the intravascular placement of port-
access cannulas, to facilitate the deairing process, and to evaluate the result
of septal closure.
Procedures
The port-access approach is a minimally invasive technique that allows
surgery via a small thoracotomy. The patient is placed in the supine position,
with the right side of the chest elevated to improve the exposure and facil-
itate the operation. A 4- to 6-cm right subthoracic incision is made (Figure 1,
A) and the fourth intercostal space is opened. After deflation of the right
lung, first a ‘‘soft tissue’’ retractor (CardioVations of Edwards Lifesciences,
Inc, Irvine, Calif) is inserted into the thoracotomy (Figure 1, B), and then
a Heartport rib retractor (CardioVations of Edwards Lifesciences) is placed
(Figure 1, C); an excellent exposure of the operative field is usually obtained
with this procedure (Figure 1, D). A pericardiotomy is made 3 cm anterior to
the phrenic nerve, and pericardial stay sutures are placed and passed out of
the chest. All patients are operated under CPB. The venous drainage is ob-
tained by cannulating both femoral (22F or 25F CardioVations long venous
cannula) and jugular vein (14F or 17F DLP arterial cannula), and the arterial
cannulation is obtained by using the femoral artery (peripheral kit) or the as-
cending aorta (central kit). When a peripheral kit is used, the right femoral
vessels are exposed through a transverse 3-cm incision in the femoral crease,
and both vein and artery (using a 21F or 23F CardioVations arterial cannula)
are cannulated through a purse-string suture and under direct vision. When
a central kit is used, the femoral vein is cannulated percutaneously, and the
ascending aorta is cannulated under direct vision with a central percutane-
ous 23F ‘‘DirectFlow’’ cannula (CardioVations of Edwards Lifesciences),ournal of Thoracic and Cardiovascular Surgpassed in a trocar through the first intercostal space, inserted into the aorta
with the ‘‘AutoIncisor’’ device (CardioVations of Edwards Lifesciences,
Inc; Figure 2), and fixed with a double purse-string suture. The aortic clamp-
ing could be obtained with an ‘‘EndoClamp’’ (central or peripheral en-
doaortic balloon) or transthoracically with the Chitwood clamp (Scanlan
International, St. Paul, Minn) or the Portaclamp system (Cardio Life Re-
search SA, Louvain la Neuve, Belgium). Both caval veins are encircled
by vascular loops and snared to install total CPB. After endoaortic or trans-
thoracic clamping, the heart is arrested with anterograde cold cardioplegia
(delivered through a DLP cannula or directly from the extremity of the bal-
loon, in case of endoaortic clamp), and the right atrium is opened longitudi-
nally. Stay sutures are placed to expose the atrial cavity and the ASD is
examined; depending on the size of the defect, the closure of the ASD
and/or the resection or plication of the interatrial aneurysm is performed ei-
ther with a simple direct closure, using single stitches of Ethibond 3-0 (Ethi-
con, Inc, Somerville, NJ) with Teflon pledgets, tied outside the atrium into
the interatrial groove, or with a polytetrafluoroethylene (PTFE) patch (W. L.
Gore & Associates, Inc., Flagstaff, Ariz). The mitral valve clefts are repaired
by using interrupted 5-0 Prolene sutures (Ethicon). The partial anomalous
pulmonary venous connections are corrected by creating a PTFE patch tun-
nel redirecting the pulmonary venous blood return into the left atrium. The
ventricular septal defect is closed with a series of Ethibond 3-0 mattress
sutures (Ethicon), supported by small PTFE pledgets. The mitral valve is
repaired using standard repair techniques, and for the tricuspid valve,
a De-Vega valvuloplasty is performed. Surgical ablation therapy for chronic
atrial fibrillation has been made with a right-sided maze procedure with ra-
diofrequency. The procedure is always carried out under mild systemic hy-
pothermia (mean esophageal temperature: 33C). After completion of the
operation, the atriotomy is closed with a 4-0 Prolene suture (Ethicon), and
decannulation is carried out. Afterward, a 24F to 28F curved chest tube is
inserted into the right pleura, a Jackson-Pratt is placed over the right atrium,
and the pericardium is closed above it, with separate stitches. After an ade-
quate hemostasis, the chest and the wounds are closed cosmetically.
Statistical Analysis
Descriptive data for continuous variables are presented as means with
standard deviation. Logistic regression models were used for univariate
analysis, and results are presented as odds ratios with their 95% confidence
intervals. Analysis was performed with STATA software (StataCorp, 2006,
Stata Statistical Software: release 9.0, College Station, Tex).RESULTS
ASD Surgery
Surgery was always performed in elective conditions, and
no conversions to median sternotomy were needed. The ar-
terial cannulation was obtained by using the femoral artery
in 78 patients (47%) and the ascending aorta in 88 patients
(53%), and the venous drainage was always obtained by
cannulating both femoral and jugular vein. The aortic clamp-
ing was performed with an endoaortic balloon in 106 pa-
tients (central kit in 50 cases and peripheral kit in 56) and
with a transthoracic clamp in the remaining 60 patients (Por-
taclamp system in 37 cases and Chitwood clamp in 23).
ASDs were corrected by primary suture (with 3 to 6 separate
stitches) in 147 patients (88.5%) and with a PTFE patch in
19 patients (11.5%). All patients had transesophageal echo-
cardiography before weaning from CPB, and no residual
ASD was detected. There was no intraoperative mortality
and no major complication. We had only 2 cases of en-
doaortic balloon rupture, which happened before we gainedery c January 2010
TABLE 1. Preoperative characteristics of population
No. of cases Mean ± SD %
Symptoms
Transient ischemic attack 61 37
Migraine 17 10
Exersional dyspnea (NYHA II-III) 87 52
Palpitations 10 60
Echocardiographic data
Size of defect (mm) 20  9
Mean PAPs (mm Hg) 36  13.5
EF (%) 60  4.5
ASA 48 29
Qp/Qs ratio 2.5  0.9
Hypertension 33 20
Dyslipidemia 12 7.2
Paroxysmal atrial fibrillation 10 6
Chronic atrial fibrillation 2 1.2
Chronic lung disease 4 2.4
Diabetes mellitus 3 1.8
Renal insufficiency 1 0.6
Surgery after transcatheter closure 2 1.2
SD, Standard deviation; NYHA, New York Heart Association; PAP, pulmonary artery
systolic pressure; EF, ejection fraction; ASA, atrial septal aneurysm; Qp/Qs ratio, pul-
monary-to-systemic blood flow ratio.
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exceeding the 450 mm Hg limit. Intraoperative characteris-
tics of patients are summarized in Table 2.Postoperative Course and Complications
Seventy-one percent (118 patients) of the population had
a completely uneventful postoperative course. All patients
were rapidly weaned from mechanical ventilation (meanFIGURE 1. A, Skin incision; B, ‘‘soft-tissue’’ retractor; C, Heart
The Journal of Thoracic and Caventilation time, 6.2  6 hours), and the mean intensive
care unit stay was 18.6  12.4 hours. Surgical revision for
bleeding from the thoracic wall was necessary in 6 cases,
and in all these patients, the source was identified and fixed
though the original thoracotomy. Postoperative paroxysmal
atrial fibrillation occurred in 24 cases, but only in 1 patient
was persistent at the time of discharge. One patient, with
complete atrioventricular block, needed a pacemaker im-
plantation. There were no hospital deaths in our series, and
the mean hospitalization time was 5.8 3.9 days. Transtho-
racic echocardiography before discharge revealed successful
repair, with no residual shunt, in all patients. Other postop-
erative data are presented in Table 3.Follow-up and Late Mortality
Follow-up was obtained in 100% of patients, and the
mean follow-up time was 51  33 months. Four patients
(2.4%) died late during follow-up. There were 2 deaths
due to Ewing’s sarcoma and 1 due to a pulmonary embolism
occurring 10 years after ASD closure. The cause of death
was unknown for 1 patient. All patients returned to a normal
life and resumed their previous activity. Improvement in
symptoms (decrease in NYHA class or improvement in ex-
ercise tolerance if preoperative NYHA class was I) occurred
in 131 patients (78%). Deterioration in functional class
occurred only in 3 patients (1.8%), and in the remaining
28 cases (all in NYHA class I preoperatively), there was
no difference in exercise tolerance after ASD closure. Pa-
tients rated the final cosmetic result of surgery (Figure 3):
98.2%were extremely satisfied and the 1.8%were satisfied.
Reoperation was not required during the follow-up period.port rib retractor; D, excellent exposure of the operative field.
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FIGURE 2. A, Central aortic cannula; B, central aortic cannula with the
‘‘AutoIncisor’’ device; C, the retractile blade of the device (arrow).
TABLE 2. Intraoperative characteristics of patients
No. of
patients Mean ± SD %
Arterial cannulation
Femoral artery 78 47
Ascending aorta 88 53
Type of clamping
Endoaortic balloon 106 64
Central kit 50 30
Peripheral kit 56 34
Transthoracically 60 36
Portaclamp system 37 22
Chitwood clamp 23 14
ASD closure technique
Primary suture 147 88.5
PTFE patch 19 11.5
CPB time (min) 64.9  34.5
Aortic cross clamp time (min) 38.4  22.2
Associated procedures 19 11.5
PARPVD repair 6 3.6
Mitral valvuloplasy 2 1.2
Mitral valve cleft closure 3 1.8
Tricuspid De-Vega valvuloplasty 4 2.4
Right-sided maze procedure
with radiofrequency
2 1.2
Ventricular septal defect closure 1 0.6
Iatrogenic AR-RA fistula closure 1 0.6
Lowest esophageal
temperature (C)
33.2  2.3
Skin incision (cm) 5.5  1
Endoaortic balloon rupture 2 1.2
Death in operating room 0 0
SD, Standard deviation; ASD, atrial septal defect; PTFE, polytetrafluoroethylene;
CPB, cardiopulmonary bypass; PARPVD, partial anomalous right pulmonary venous
drainage; AR-RA, aortic root-to-right atrium.
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incision was fairly well tolerated by all patients. Postopera-
tive echocardiography was collected for 86% of patients and
revealed a trivial residual shunt only in 2 cases. All patients,
except 1 with known carotid artery disease, stopped antiag-
gregation therapy after surgery, and no new cerebral epi-
sodes were reported during the follow-up period. Five
patients (3%) developed paroxysmal atrial fibrillation post-
operatively, and another 3 (1.8%) needed a pacemaker im-
plant due to severe bradycardia. Two patients (1.2%)
developed pericarditis that was medically treated.DISCUSSION
Surgical closure of ASDs with median sternotomy has
been considered the standard approach for almost 50 years.
This is a low-risk surgical method, with no operative
mortality, very low morbidity, and excellent long-term
outcome.9,10 Why, then, should we diverge from a high-
benefit and low-risk procedure? Obviously because this ap-142 The Journal of Thoracic and Cardiovascular Surgproach entails operative trauma and large surgical wounds,
which may cause psychologic distress and negative influ-
ence on the quality of life of young and often female pa-
tients, who are usual candidates for ASD repair. In this
‘‘incisionless era,’’ a 20-cm skin incision is probably no lon-
ger considered acceptable to repair a 2-cm septal defect, but
cosmetic results must be balanced against the safety of the
procedure. In the past several years, we have seen the devel-
opment of various minimally invasive approaches as a result
of technical innovations in surgical instruments, CPB tech-
nology, and transthoracic and endovascular clamping.5-7
At our institution, the port-access surgery, via a right mini-
thoracotomy in the fourth intercostal space, has become
the standard approach not only for ASDs closure but also
in cases of mitral valve surgery, tricuspid valve surgery,
atrial myxoma, surgical treatment of atrial fibrillation, and
ventricular septal defects (membranous or inlet types). After
10 years’ experience, with more than 1200 patients operated
on with this method, ASD repair is no longer considered
a challenging and time-consuming procedure at our center.11ery c January 2010
TABLE 3. Postoperative course and complications
No. of patients Mean ± SD %
ICU stay (h) 18.6  12.4
Ventilation time (h) 6.2  6
Hospitalization total (d) 5.8  3.9
24-h drainage (mL) 310  215
Drainage (d) 2.1  0.8
Paroxysmal atrial fibrillation 24 14.4
Persistent atrial fibrillation 1 0.6
Surgical revision for bleeding 6 3.6
Hyperthermia 7 4.2
Pacemaker implantation 1 0.6
Pneumothorax 3 1.8
Transfusions 9 5.4
Inguinal lymphorrhea 1 0.6
SD, Standard deviation; ICU, intensive care unit.
FIGURE 3. Excellent cosmetic result of surgery.
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ing times for ASDs closure were 64.9  34.5 and 38.4 
22.2 minutes, respectively. These results are comparable
with those reported in other series, whether lower partial
sternotomy,12 right thoracotomy5,13 or varied minimally in-
vasive surgical approaches7 were performed. The latest step
in the surgical evolution of ASD repair is robotic technol-
ogy.6,14,15 By avoiding thoracotomy incisions and rib
spreading, this procedure results in minimal pain and post-
operative recovery time, overall patient satisfaction, and
excellent cosmesis, but it has some certain limitations. First,
it is technically challenging and time-consuming, with CPB
and aortic crossclamping times almost double compared
with the reported experiences with port-access approach.7,13
Moreover, in our study, surgery was performed with shorter
operative times, although procedure duration is longer in
case of PTFE patch closure (11.5% in our series) and asso-
ciated procedures (11.5% in our series). Second, costs for
robotic surgery are still very high, and the hospital length
of stay of patients (from 4 to 9.5 days)6,14,15 is not lower if
compared with our port-access experience (5.8 days) and
that of others (from 3.98 to 8.2 days).5,7,13 Finally, the ab-
sence of tactile feedback with robotic assistance could turn
a simple suture into a technically difficult procedure that en-
tails potential risk of ASD recurrence.6,7 In our study, com-
plete closure of ASD was confirmed in all patients with
intraoperative transesophageal echocardiography, and no
significant residual shunts were identified after a mean fol-
low-up time of 51 months.
Surgical strategy and good exposure were the keys to the
success of this minimally invasive approach. By using both
a soft tissue retractor and a rib retractor, we always obtained
an excellent exposure of the operative field. Both arterial and
venous cannulations were kept out of the operative field. The
fact that both femoral and jugular vein were cannulated, en-
circled by vascular loops and snared, allowed perfect venous
drainage in almost all cases. Furthermore, the possibility ofThe Journal of Thoracic and Caperforming a central arterial cannulation makes this tech-
nique suitable also for patients with peripheral vascular dis-
ease involving the iliac or femoral vessels.
Another advantage of this type of surgery, compared with
standard sternotomy, is the fact that patients needing reoper-
ation can be operated on using a different surgical approach.
Therefore, reentry problems are avoided as a wide dissection
is not necessary, a peripheral arterial cannulation can be
performed, and the aortic clamping can be obtained with
an EndoClamp. On the other hand, this minimally invasive
approach could create fewer adhesions in the long term, con-
sidering the fact that intrathoracic dissection and trauma are
limited. This could be crucial in the case of future reopera-
tion, especially in a population of relatively younger people.
After using different perfusion (central and peripheral can-
nulation) and aortic clamping (endoclamp or transthoracic
clamp) techniques, we report here our preferred approach
for a specific clinical context: (1) peripheral vascular disease
or aortic atheroma: central cannulation; (2) patients needing
reoperation: peripheral cannulation; (3) aortic diameter>35
mm: central cannulation with transthoracic clamping (risk of
incomplete aortic endoclamping); (4) aortic diameter< 20
mm: peripheral cannulation (risk of injury to the posterior
wall of the aorta using the AutoIncisor device); (5) female pa-
tients: peripheral cannulation (preferred; unaesthetic scar
over the right breast due to the transthoracic clamp in case
of central cannulation); (6) obesity and/or diabetes mellitus:
central cannulation (presumed augmented risk of inguinal
lymphorrhea or infection in the femoral groove). In the
case of peripheral cannulation, aortic crossclamping is ob-
tained with an endoclamp, and in the case of central cannula-
tion, the Chitwood clamp is actually our preferred (lower cost
if compared with the Portaclamp).rdiovascular Surgery c Volume 139, Number 1 143
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scribed,16 the port-access approach is a low-risk and highly
successful procedure: in our series all patients survived the
operation, and no major surgical complication was experi-
enced. These achievements may be related to our well-estab-
lished experience in minimally invasive surgery and to
technical improvements in CPB, surgical instruments, and
clamping devices. We did not encounter any thromboem-
bolic event or complication related to peripheral cannulation,
such as iliofemoral or aortic retrograde dissections. These
theoretical disadvantages of port-access approach could oc-
cur especially in the case of diffuse atherosclerosis, which
is an uncommon situation in a relatively young population
such as the one considered in our study. However, if neces-
sary, a central arterial cannulation, associated with transtho-
racic clamping, can be employed to prevent these risks in
patients with peripheral vascular disease or aortic atheroma.
Another reported drawback of the port-access approach is
phrenic nerve damage. In this ASDs cohort, we did not expe-
rience any injury to the nerve, but it was a complication that
was noted at the beginning of our general experience with
port-access surgery. We believe that it could be easily pre-
vented by a careful definition of the course of the phrenic
and by opening the pericardium 2 cm away from it, avoiding
the use of topical cooling. Surgical revision for bleeding from
the thoracic wall was necessary in 6 patients, but this was
another complication encountered only at the beginning of
our experience. The main cause of bleeding was the injury
to an intercostal artery, an accident that can easily occur con-
sidering the peculiar characteristics of this type of surgery
(transthoracic clamping, central percutaneous arterial cannu-
lation, pericardial stay sutures passed out of the chest). Con-
cerning postoperative pain, Walther and colleagues17 reported
higher pain levels during the first 2 postoperative days in
patients operated on through a minithoracotomy. With this
approach, in fact, the rib-spreading effect can produce inter-
costal nerve damage and consequent increase of postopera-
tive pain. In our study, we did not perform pain scoring,
considering that pain perception is difficult to standardize
and that individual thresholds can vary according to differ-
ences in sex, age, race, and socioeconomic status. However,
the use of soft tissue retractors during operation and antalgic
therapy postoperatively can help to control or minimize pain.
New-onset paroxysmal atrial fibrillation was the most
common postoperative complication observed in our series
(14.4%). Nevertheless, in only 1 patient (0.6%) was this
persistent at the time of discharge. Older age at surgery
was the only predictor of paroxysmal atrial fibrillation
(P < .0001; odds ratio, 1.08; 95% confidence interval,
1.04–1.12) between all pre- and intraoperative variables
considered in our univariate analysis. Possible mechanisms
involved in these patients are long-standing right atrial dila-
tation, atrial fibrosis, and pulmonary hypertension, probably
amplified by the effect of surgical scars.18,19144 The Journal of Thoracic and Cardiovascular SurgFinally, regarding a comparison of this minimally inva-
sive technique with interventional approaches involving
different occluder systems, several points should be consid-
ered. First, device closure is impracticable or unsuitable in
the following cases: (1) defects too large for occlusion; (2)
multiple defects; (3) coronary sinus defects; (4) defects asso-
ciated with atrial septal aneurysm, mitral valve cleft, or par-
tial abnormal pulmonary vein connection; (5) distance of<5
mm from the margins of the ASD to the pulmonary veins,
atrioventricular valves, coronary sinus, or superior vena
cava; (6) presence of associated cardiac pathologies requir-
ing surgical repair. The 20.5% of the ASDs in our series
were complex (9%) or associated with other cardiac anom-
alies (11.5%); therefore, this cohort demonstrates that all
types of defect can be safely approached and corrected by
port-access surgery. Second, interventional techniques for
ASDs closure are associated with a 95% early efficacy,3,4
and successful closure is achieved in 100% of patients
treated by surgery.3,7,16,20 Even if residual shunts after de-
vice closure are often not hemodynemically significant and
most will close spontaneously within 1 year,3 it remains
true that, on the other hand, surgical repair ensures an effec-
tive repair in all patients (including those with complex de-
fects) and, most importantly, with excellent long-term
outcome.10 The limited follow-up of most reported series
of transcatheter closure and the lack of randomized studies
comparing interventional and surgical therapies make it im-
prudent to conclude that interventional techniques are com-
parable or even preferable to the surgical approach,
regardless of patient selection.21,22 Third, despite the techni-
cal improvements in transcatheter occluder devices, several
major complications are still documented: (1) device dislo-
cation and consequent peripheral embolization; (2) signifi-
cant residual defect requiring surgical reoperation; (3)
neurologic events during or after procedure; (4) early cardiac
perforation with tamponade; (5) injuries to intracardiac
structures; (6) obstruction to systemic and pulmonary ve-
nous drainage; (7) endocarditis; (8) postprocedural thrombo-
embolic risk; (9) late erosion or perforation of the atrial wall
and the aortic root.3,20,21,23,24 Although uncommon (occur-
ring in around 1%–2% of patients), these complications
may lead to extremely dangerous consequences (cardiac
failure, death, or stroke) and a poor outcome in patients
with a relatively benign defect. Walther and colleagues20 re-
ported a series of 15 patients requiring secondary surgical
therapy after interventional occluder placement; the func-
tional outcome of this population was excellent, even in
the presence of severe complications. In our study, we had
2 cases of incomplete occlusion of ASD after transcatheter
closure, associated, in 1 patient, with an iatrogenic aortic
root-to-right atrium fistula (as previously reported in de-
tail).23 In both cases, the device was removed, the correction
was easily performed, and the postoperative course was un-
eventful, ensuring a satisfactory clinical outcome. Briefly,ery c January 2010
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larity among patients and cardiologists, but, as serious com-
plications may occur using this technique, in our opinion,
a surgical standby should be preferable. Finally, device clo-
sure of ASD is shown to be associated with shorter hospital
stay, better quality of life, and earlier return to normal activ-
ity compared with the surgical approach. This can be true if
we consider only the conventional sternotomy but, in the
current era of minimally invasive surgery, a comparison
must be made to the port-access approach. In fact, a less in-
vasive surgical technique ensures a low-risk and highly suc-
cessful procedure, with low morbidity, a short hospital stay,
early mobilization and return to work, good cosmesis, and
high patient satisfaction, and, what is more, with an excellent
long-term result.
CONCLUSIONS
From our experience, port-access minimally invasive sur-
gery for ASDs is a safe, minimally invasive, reproducible,
and cosmetic operation that guarantees an outstanding clin-
ical result and a durable anatomic correction. These achieve-
ments are reached even in the presence of complex defects
or associated cardiac pathologies. Percutaneous techniques
will probably remain in the treatment of selected ASDs
but the port-access approach should now be considered the
standard treatment option. Only a real perspective random-
ized trial, comparing transcatheter and minimally invasive
surgical closure, can provide an incontrovertible answer.
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